Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
US Public Health Service Commissioned Corps, Rockville, Maryland, USA.
Inj Prev. 2022 Dec;28(6):545-552. doi: 10.1136/ip-2022-044620. Epub 2022 Aug 3.
Medication poisoning is a common form of self-harm injury, and increases in injuries due to self-harm, including suicide attempts, have been reported over the last two decades.
Cross-sectional (2016-2019) data from 60 emergency departments (EDs) participating in an active, nationally representative public health surveillance system were analysed and US national estimates of ED visits for medication-related self-harm injuries were calculated.
Based on 18 074 surveillance cases, there were an estimated 269 198 (95% CI 222 059 to 316 337) ED visits for medication-related self-harm injuries annually in 2016-2019 compared with 1 404 090 visits annually from therapeutic use of medications. Population rates of medication-related self-harm ED visits were highest among persons aged 11-19 years (58.5 (95% CI 45.0 to 72.0) per 10 000) and lowest among those aged ≥65 years (6.6 (95% CI 4.4 to 8.8) per 10 000). Among persons aged 11-19 years, the ED visit rate for females was four times that for males (95.4 (95% CI 74.2 to 116.7) vs 23.0 (95% CI 16.4 to 29.6) per 10 000). Medical or psychiatric admission was required for three-quarters (75.1%; 95% CI 70.0% to 80.2%) of visits. Concurrent use of alcohol or illicit substances was documented in 40.2% (95% CI 36.8% to 43.7%) of visits, and multiple medication products were implicated in 38.6% (95% CI 36.8% to 40.4%). The most frequently implicated medication categories varied by patient age.
Medication-related self-harm injuries are an important contributor to the overall burden of ED visits and hospitalisations for medication-related harm, with the highest rates among adolescent and young adult females. These findings support continued prevention efforts targeting patients at risk of self-harm.
药物中毒是一种常见的自残伤害形式,在过去二十年中,自残伤害包括自杀未遂的报告有所增加。
对参与主动、全国代表性公共卫生监测系统的 60 个急诊部(ED)的横断面(2016-2019 年)数据进行分析,并计算了与药物相关的自我伤害性损伤的美国 ED 就诊的全国估计数。
基于 18074 例监测病例,估计 2016-2019 年每年有 269198 例(95%CI222059 至 316337 例)与药物相关的自我伤害性损伤的 ED 就诊,而每年因药物治疗而就诊的次数为 1404090 次。药物相关自我伤害性 ED 就诊的人群率在 11-19 岁人群中最高(每 10000 人中有 58.5(95%CI45.0 至 72.0)),在≥65 岁人群中最低(每 10000 人中有 6.6(95%CI4.4 至 8.8))。在 11-19 岁人群中,女性的 ED 就诊率是男性的四倍(95.4(95%CI74.2 至 116.7)与 23.0(95%CI16.4 至 29.6)每 10000 人)。四分之三(75.1%;95%CI70.0%至 80.2%)的就诊者需要住院治疗。40.2%(95%CI36.8%至 43.7%)的就诊者记录了同时使用酒精或非法药物,38.6%(95%CI36.8%至 40.4%)的就诊者涉及多种药物产品。不同年龄段的患者涉及的最常见药物类别有所不同。
与药物相关的自我伤害性损伤是 ED 就诊和与药物相关伤害住院治疗的总体负担的一个重要因素,青少年和年轻成年女性的发生率最高。这些发现支持针对有自我伤害风险的患者持续进行预防工作。